Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
22 participants
INTERVENTIONAL
2008-09-30
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
resistance training
Resistance training
Neck muscle trainings effect on botulinum toxin efficiency
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resistance training
Neck muscle trainings effect on botulinum toxin efficiency
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Spasticity in splenius capitis muscle
* Regular treatment with botulinum toxin injection
Exclusion Criteria
* Very long distance from home to Jyväskylä Central Hospital
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eurostars
OTHER
Jyväskylä Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jyvaskylä Central Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jari Ylinen, MD, PhD
Role: STUDY_DIRECTOR
Senior physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Finland Helth Care District
Jyväskylä, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSKS
Identifier Type: -
Identifier Source: org_study_id